TrialScope is part of Informa Pharma Intelligence, a division of Informa Business Intelligence, Inc. (IBI). IBI is a wholly-owned subsidiary of Informa PLC.

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

TrialScope Connect™ Named One of the Most Innovative Products of 2020 by PM360


December 10, 2020

JERSEY CITY, NJ (Dec. 10, 2020) —  PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named TrialScope Connect as one of the most innovative products of 2020.

Launched in October 2019, the TrialScope Connect referral collective brings together a broad range of stakeholders — recruitment companies, advocacy groups and healthcare organizations — to better match patients to clinical trials. This industry-first model focuses on results rather than effort, collaboration instead of competition. The platform enables sponsors to:

  • Post a trial and tap into a growing community of 75-plus diverse and vetted recruitment partners that can simultaneously recruit and refer patients from a combined pool of millions of patients
  • Incorporate digital prequalification screeners earlier in the process to reduce patient and site burden
  • Connect patients directly to sites, bypassing delays of a centralized triage inbox and ensuring no referrals fall through the cracks

“In just over a year, TrialScope Connect is quickly becoming the go-to solution for sponsors and recruitment partners eager to accelerate and optimize the trial recruitment process, ease the burden on trial sites, and most importantly, benefit the patient,” said Mike Wenger, TrialScope Vice President of Patient Engagement. “Most recently, we helped a sponsor across the finish line in reaching all of its diversity enrollment goals on a COVID-19 study.”

TrialScope Connect was selected as part of PM360’s 9th Annual Innovations Issue published each December. This issue serves as a guide to the year’s most innovative companies, startups, divisions, products, services and strategies in the healthcare and life sciences industries.

“Innovation has been and will continue to be crucial as our industry and the world at large continue to deal with COVID-19 and the disruption and devastation it has caused,” said Anna Stashower, CEO, Publisher and Editor-in-Chief of PM360.

PM360 received hundreds of submissions from across the healthcare and life sciences industries. The editorial staff of PM360 evaluated each submission and selected their picks for the most innovative, regardless of category. Ultimately, 64 total innovations are featured in the issue, 16 in the product category.

For more information on TrialScope and TrialScope Connect, visit

About TrialScope 

TrialScope gives your clinical trial data superpowers™. The TrialScope Transparency Cloud™ makes centralizing, structuring and activating clinical trial information simple, for use across the organization and at every stage of the study. Our integrated platform is used by 16 of the top 20 clinical trial sponsors in the world, who rely on TrialScope to ensure disclosure compliance, maximize trial transparency, improve patient engagement and accelerate study recruitment. To learn more, visit

TrialScope was acquired by Informa Pharma Intelligence earlier in 2020, combining its powerful technology for disclosure, transparency and recruitment with leading brands, data and solutions for the clinical trials and broader pharmaceutical and biomedical industry.

About Informa Pharma Intelligence

Informa Pharma Intelligence powers a full suite of analysis products — Datamonitor Healthcare™, Sitetrove™, Trialtrove™, Pharmaprojects™, Medtrack™, Biomedtracker™, Scrip™, Pink Sheet™ In Vivo™ and most recently TrialScope — to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth. With more than 500 analysts keeping their fingers on the pulse of the industry, no key disease, clinical trial, drug approval or R&D project isn’t covered through the breadth and depth of data available to customers. For more information visit

About PM360

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.